drugset / Trial / NCT03330782

Remifentanil for Preventing Propofol Injection Pain in Elderly Patients

NCT03330782 ↗

Phase 4 Completed 52 enrolled Ajou University School of Medicine
Non-randomizedParallel-groupDouble-blindPrevention

Summary

Elderly patients show different pharmacokinetic and pharmacodynamic variables and usually need smaller doses of anesthetic drugs than younger patients. The purpose of this study was to investigate the optimal effect-site concentration of remifentanil for preventing injection pain during propofol induction in elderly patients by the Dixon's up-and-down method.

Timeline

Start
2017-11-16
Primary completion
2018-06-15
Completion
2018-06-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Remifentanil Small molecule 3 ng/ml —

Indications